Biomarkers — The Value of FeNO in Predicting Airway Eosinophilic Inflammation
Citation(s)
Alving K, Malinovschi A Basic aspects of exhaled nitric oxide. European Respiratory Monograph. 2010;49:1-31.
Antus B, Barta I, Horvath I, Csiszer E Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations. Respirology. 2010 Apr;15(3):472-7. doi: 10.1111/j.1440-1843.2010.01711.x. Epub 2010 Feb 24.
Oh MJ, Lee JY, Lee BJ, Choi DC Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough. Chest. 2008 Nov;134(5):990-995. doi: 10.1378/chest.07-2541. Epub 2008 Jun 26.
Prieto L, Ferrer A, Ponce S, Palop J, Marín J Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough. Chest. 2009 Sep;136(3):816-822. doi: 10.1378/chest.08-2942. Epub 2009 May 1.
Saha S, Brightling CE Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):39-47. Review.
Zhang YM, Lin JT [The values of fractional exhaled nitric oxide in the diagnosis and treatment of chronic cough]. Zhonghua Jie He He Hu Xi Za Zhi. 2011 Jul;34(7):504-8. Chinese.
Zietkowski Z, Kucharewicz I, Bodzenta-Lukaszyk A The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease. Respir Med. 2005 Jul;99(7):816-24.
The Value of Exhaled Nitric Oxide in Predicting Airway Eosinophilic Inflammation in Chronic Airway Inflammatory Disease
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.